Cephalon Will Pursue New Gabitril Uses After Acquisition Of Anti-Epileptic
Executive Summary
Cephalon plans to develop Gabitril for indications outside of epilepsy, the company said after announcing the acquisition of the product from Abbott Nov. 1.